About Cellcolabs
Cellcolabs is a company based in Solna (Sweden) founded in 2021. Cellcolabs has raised $24.99 million across 3 funding rounds from investors including Fredrik Österberg, Jens von Bahr and unknown. Cellcolabs offers products and services including Mesenchymal Stromal Cells. Cellcolabs operates in a competitive market with competitors including Cryo-Cell, China Cord Blood Corporation, BioLife Plasma Services, FamilyCord and Lazo de Vida, among others.
- Headquarter Solna, Sweden
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$24.99 M (USD)
in 3 rounds
-
Latest Funding Round
$12 M (USD), Series A
Oct 26, 2025
-
Investors
unknown
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cellcolabs
Cellcolabs offers a comprehensive portfolio of products and services, including Mesenchymal Stromal Cells.
High-quality cells produced for research and clinical applications.
People of Cellcolabs
Unlock access to complete
Funding Insights of Cellcolabs
Cellcolabs has successfully raised a total of $24.99M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $12 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cellcolabs
Cellcolabs has secured backing from 6 investors, including angel and venture fund investors. Prominent investors backing the company include Fredrik Österberg, Jens von Bahr and unknown.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
FÖ
Fredrik Österberg |
-
|
Locked | Locked | Locked |
|
JV
Jens von Bahr |
Co-founder of Evolution Gaming, active angel investor in Indian startups
|
Locked | Locked | Locked |
Investor details for Cellcolabs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cellcolabs
Investment portfolio details for Cellcolabs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cellcolabs
Detailed financials for Cellcolabs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellcolabs Comparisons
Peer comparison for Cellcolabs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cellcolabs
Cellcolabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cryo-Cell, China Cord Blood Corporation, BioLife Plasma Services, FamilyCord and Lazo de Vida, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cord blood and tissue stem cells are stored for preservation.
|
|
| Locked | Locked | Locked |
Umbilical cord blood stem cell banking services are provided.
|
|
| Locked | Locked | Locked |
BioLife Plasma Services collects high-quality plasma and processes it into lifesaving therapies.
|
|
| Locked | Locked | Locked |
Provides comprehensive stem cell storage services for individuals.
|
|
| Locked | Locked | Locked |
Provider of stem cell banking services
|
Detailed competitors of Cellcolabs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellcolabs
Complete news archive for Cellcolabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellcolabs
Cellcolabs was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Cellcolabs is headquartered in Solna, Sweden.
Mattias Bernow is the current CEO of Cellcolabs.
Cellcolabs is a funded company, having raised a total of $24.99M across 3 funding rounds to date.
Cellcolabs was founded in 2021 and is based in Solna, Sweden. Stem cell banking services are offered to support the healthcare sector, with a focus on storage and preservation for medical applications. Operations are conducted in the biotechnology domain, emphasizing reliable solutions for stem cell management. The company is led by CEO Mattias Bernow, ensuring strategic oversight in this specialized field.
Cellcolabs's top competitors include Cryo-Cell, China Cord Blood Corporation and Lazo de Vida.
Cellcolabs offers Mesenchymal Stromal Cells.
Cellcolabs has 6 investors. Key investors include Fredrik Österberg, Jens von Bahr, unknown, Norrsken Foundation, and Johannes Schildt.